Dr. Jamie Brisbois is a manager, business development and licensing based in New York City. In this role, he collaborates with Weill Cornell Medicine innovators to identify, market, and license life sciences technologies.
Prior to joining the Center for Technology Licensing in 2021, Dr. Brisbois worked as a consultant with ClearView Healthcare Partners, a boutique healthcare consulting firm based in Boston. In addition, he served three years as a fellow with Columbia Technology Ventures (CTV), the technology transfer office of Columbia University.
Dr. Brisbois received his Ph.D. in Chemistry from Columbia University, where he helped develop a scalable signaling language for engineering multicellular communication in the laboratory of Dr. Virginia Cornish. He holds a B.A. in Chemistry, Biochemistry, and French from Lawrence University (Appleton, WI), where he graduated Magna Cum Laude.
Dr. Brisbois partners with innovators from the departments of Biochemistry, Microbiology and Immunology, and Pharmacology.
